Because these data strongly highlight a direct correlation between GPBAR1 and GLP-1 expression and GLP-1 and ACE2, we then investigated whether blocking GLP-1 signaling in the TNBS model of colitis reverts upregulation of ACE2 in response to BAR501. Here, GCG is linked to colitis.